Kiniksa Pharmaceuticals Ltd (KNSA)
17.62
-0.24
(-1.37%)
USD |
NASDAQ |
Apr 25, 16:00
17.62
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 60.63% |
| June 30, 2023 | 69.66% |
| March 31, 2023 | 68.30% |
| December 31, 2022 | |
| September 30, 2022 | 88.34% |
| Date | Value |
|---|---|
| June 30, 2022 | 67.74% |
| March 31, 2022 | 61.25% |
| December 31, 2021 | 79.37% |
| September 30, 2021 | 77.12% |
| June 30, 2021 | 67.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
60.63%
Minimum
Sep 2023
88.34%
Maximum
Sep 2022
71.16%
Average
68.30%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 90.16% |
| Geron Corp | -- |
| United Therapeutics Corp | 88.45% |
| Vanda Pharmaceuticals Inc | 92.36% |
| TG Therapeutics Inc | 82.14% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.45% |
| Return on Assets | 2.94% |
| Return on Invested Capital | 3.45% |
| Profit Margin (Quarterly) | 30.26% |
| Operating Margin (Quarterly) | 0.10% |
| Return on Net Operating Assets | 20.39% |